{"altmetric_id":1701501,"counts":{"readers":{"mendeley":27,"citeulike":0,"connotea":0},"googleplus":{"unique_users_count":2,"unique_users":["Pal Daily","Shantanu Kumar"],"posts_count":4},"news":{"unique_users_count":2,"unique_users":["medwirenews","mta_dialog"],"posts_count":2},"total":{"posts_count":11},"twitter":{"unique_users_count":4,"unique_users":["CRWLibrary","valdesan","JoaquinJCabrera","AmadeoWals"],"posts_count":5}},"selected_quotes":["Concurrent chemoradiation leads to survival and quality of life benefits in stage III non-small-cell lung cancer","Palliative chemoirradiation in stage III lung cancer. So wide spectrum of patients. Where's the cut-off?","BJC Open:Concurrent palliative chemoradiation leads to survival QOL benefits in poor prognosis stage III NSCLC"],"citation":{"abstract":"The palliative role of chemoradiation in the treatment of patients with locally advanced, inoperable non-small-cell lung cancer stage III and negative prognostic factors remains unresolved.","abstract_source":"pubmed","altmetric_jid":"4f6fa4e93cf058f61000243d","authors":["H H Str|[oslash]|m","R M Bremnes","S H Sundstr|[oslash]|m","N Helbekkmo","|[Oslash]| Fl|[oslash]|tten","U Aaseb|[oslash]|"],"doi":"10.1038\/bjc.2013.466","endpage":"","first_seen_on":"2013-08-21T09:39:54+00:00","issns":["0007-0920","1532-1827"],"journal":"British Journal of Cancer","last_mentioned_on":1456775050,"links":["http:\/\/www.nature.com\/bjc\/journal\/vaop\/ncurrent\/abs\/bjc2013466a.html","http:\/\/www.nature.com\/bjc\/journal\/v109\/n6\/pdf\/bjc2013466a.pdf","http:\/\/www.nature.com\/bjc\/journal\/v109\/n6\/full\/bjc2013466a.html","http:\/\/dx.doi.org\/10.1038\/bjc.2013.466","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23963145"],"pmid":"23963145","pubdate":"2013-08-20T00:00:00+00:00","publisher":"Nature Publishing Group","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Biochemistry, Genetics and Molecular Biology"],"startpage":"","subjects":["neoplasms"],"title":"Concurrent palliative chemoradiation leads to survival and quality of life benefits in poor prognosis stage III non-small-cell lung cancer: a randomised trial by the Norwegian Lung Cancer Study Group","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/concurrent-palliative-chemoradiation-leads-survival-quality-life-benefits-poor-prognosis-stage-iii-n-3"},"altmetric_score":{"score":20,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":20},"context_for_score":{"all":{"total_number_of_other_articles":7313486,"mean":6.3735475029997,"rank":345695,"this_scored_higher_than_pct":95,"this_scored_higher_than":6965619,"rank_type":"exact","sample_size":7313486,"percentile":95},"similar_age_3m":{"total_number_of_other_articles":127877,"mean":6.9048556883232,"rank":7374,"this_scored_higher_than_pct":94,"this_scored_higher_than":120467,"rank_type":"exact","sample_size":127877,"percentile":94},"this_journal":{"total_number_of_other_articles":3735,"mean":8.763408677022,"rank":233,"this_scored_higher_than_pct":93,"this_scored_higher_than":3500,"rank_type":"exact","sample_size":3735,"percentile":93},"similar_age_this_journal_3m":{"total_number_of_other_articles":115,"mean":7.015649122807,"rank":11,"this_scored_higher_than_pct":90,"this_scored_higher_than":104,"rank_type":"exact","sample_size":115,"percentile":90}}},"demographics":{"poster_types":{"member_of_the_public":2,"practitioner":2},"users":{"twitter":{"cohorts":{"Practitioners (doctors, other healthcare professionals)":2,"Members of the public":2}},"mendeley":{"by_status":{"Unspecified":1,"Professor > Associate Professor":2,"Librarian":1,"Researcher":5,"Student  > Ph. D. Student":6,"Student  > Postgraduate":1,"Other":2,"Student  > Bachelor":3,"Lecturer > Senior Lecturer":2,"Professor":1},"by_discipline":{"Medicine and Dentistry":16,"Physics and Astronomy":1,"Agricultural and Biological Sciences":1,"Computer Science":1,"Nursing and Health Professions":2,"Unspecified":3}}},"geo":{"twitter":{"GB":1,"ES":2}}},"posts":{"googleplus":[{"url":"https:\/\/plus.google.com\/108018156567442433214\/posts\/PXChe6qY9Wi","citation_ids":[1701501],"posted_on":"2013-08-21T11:21:03+00:00","summary":"British Journal of Cancer - Concurrent palliative chemoradiation leads to survival and quality of life benefits in poor prognosis stage III non-small-cell lung cancer: a randomised trial by the Norwegian Lung Cancer Study Group The BJC is owned by Cancer R","author":{"name":"Pal Daily","url":"https:\/\/plus.google.com\/+PalDaily","image":"https:\/\/lh3.googleusercontent.com\/-SL1VLOCDBvE\/AAAAAAAAAAI\/AAAAAAAAAaw\/55zyrZD-DEY\/photo.jpg?sz=50","id_on_source":"108018156567442433214"}},{"url":"https:\/\/plus.google.com\/112535748497564391228\/posts\/WX2XrGasC8F","citation_ids":[1701501],"posted_on":"2013-09-19T12:01:25+00:00","summary":"www.nature.com\/bjc\/journal\/v109\/n6\/pdf\/bjc2013466a.pdf http:\/\/www.nature.com\/bjc\/journal\/v109\/n6\/pdf\/bjc2013466a.pdf","author":{"name":"Shantanu Kumar","url":"https:\/\/plus.google.com\/+ShantanuKumarIndia","image":"https:\/\/lh3.googleusercontent.com\/-GOEs7GWOQeo\/AAAAAAAAAAI\/AAAAAAAAL08\/UmcfKe7x4xY\/photo.jpg?sz=50","id_on_source":"112535748497564391228"}},{"url":"https:\/\/plus.google.com\/108018156567442433214\/posts\/TLq6f1y6KLY","citation_ids":[1701501],"posted_on":"2013-09-18T13:53:47+00:00","summary":"British Journal of Cancer - Concurrent palliative chemoradiation leads to survival and quality of life benefits in poor prognosis stage III non-small-cell lung cancer: a randomised trial by the Norwegian Lung Cancer Study Group The BJC is owned by Cancer R","author":{"name":"Pal Daily","url":"https:\/\/plus.google.com\/+PalDaily","image":"https:\/\/lh3.googleusercontent.com\/-SL1VLOCDBvE\/AAAAAAAAAAI\/AAAAAAAAAaw\/55zyrZD-DEY\/photo.jpg?sz=50","id_on_source":"108018156567442433214"}},{"url":"https:\/\/plus.google.com\/108018156567442433214\/posts\/NzNXV5uSatg","citation_ids":[1701501],"posted_on":"2013-09-18T13:53:16+00:00","summary":"British Journal of Cancer - Concurrent palliative chemoradiation leads to survival and quality of life benefits in poor prognosis stage III non-small-cell lung cancer: a randomised trial by the Norwegian Lung Cancer Study Group The BJC is owned by Cancer R","author":{"name":"Pal Daily","url":"https:\/\/plus.google.com\/+PalDaily","image":"https:\/\/lh3.googleusercontent.com\/-SL1VLOCDBvE\/AAAAAAAAAAI\/AAAAAAAAAaw\/55zyrZD-DEY\/photo.jpg?sz=50","id_on_source":"108018156567442433214"}}],"news":[{"title":"Palliative chemoradiation boosts survival, QoL in poor-prognosis NSCLC","url":"http:\/\/www.medwirenews.com\/379\/104958\/Lung_cancer\/Palliative_chemoradiation_boosts_survival,_QoL_in_poor-prognosis_NSCLC.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+MedWireNews+%28MedWire+News%29","license":"public","citation_ids":[1701501],"posted_on":"2013-10-10T00:00:00+00:00","summary":"C hemoradiation is superior to chemotherapy alone with respect to both survival and quality of life in patients with inoperable non-small-cell lung cancer, a phase III trial has found.","author":{"name":"medwireNews","url":"http:\/\/www.medwirenews.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/070\/normal\/image.png?1369859687"}},{"title":"Selbst bei weit fortgeschrittenem Lungenkrebs verl\u00e4ngert Strahlentherapie das \u00dcberleben","url":"http:\/\/www.mta-dialog.de\/news\/krebstherapie-selbst-bei-weit-fortgeschrittenem-lungenkrebs-verlaengert-strahlentherapie-das-ueberleben.htm","license":"public","citation_ids":[1701501],"posted_on":"2014-04-22T22:00:00+00:00","summary":"Mehr als 50.000 Menschen in Deutschland erkranken pro Jahr an Lungenkrebs. Eine Strahlentherapie kann fortgeschrittenen Lungenkrebs zwar h\u00e4ufig nicht mehr heilen, den Tumor aber oft zumindest vor\u00fcbergehend zur\u00fcckdr\u00e4ngen. Dies gelang in einer aktuellen Stud","author":{"name":"MTA Dialog","url":"http:\/\/www.mta-dialog.de","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/583\/normal\/image.png?1392912568"}}],"twitter":[{"url":"http:\/\/twitter.com\/CRWLibrary\/statuses\/370117737646784512","license":"public","citation_ids":[1701501],"posted_on":"2013-08-21T09:38:39+00:00","author":{"name":"Cancer Library VCC","url":"http:\/\/www.wales.nhs.uk\/velindrelibrary","image":"https:\/\/pbs.twimg.com\/profile_images\/478464349476884480\/YlBsicot_normal.jpeg","description":"The only cancer specialist library service in Wales.  Supporting NHS and academic staff, students and health professionals throughout the Principality.","id_on_source":"CRWLibrary","tweeter_id":"1288296943","geo":{"lt":51.48,"ln":-3.18,"country":"GB"},"followers":650},"tweet_id":"370117737646784512"},{"url":"http:\/\/twitter.com\/valdesan\/statuses\/370305191074996224","license":"datasift","citation_ids":[1701501],"posted_on":"2013-08-21T22:03:32+00:00","author":{"name":"Rafael S-D","image":"https:\/\/pbs.twimg.com\/profile_images\/1637351499\/image_normal.jpg","description":"medical oncologist. focus in novel therapeutics for lung, head and neck cancers.","id_on_source":"valdesan","tweeter_id":"28646576","geo":{"lt":null,"ln":null},"followers":207},"tweet_id":"370305191074996224"},{"url":"https:\/\/twitter.com\/JoaquinJCabrera\/status\/382505878433579008","license":"public","rt":["AmadeoWals"],"citation_ids":[1701501],"posted_on":"2013-09-24T14:04:42+00:00","author":{"id_on_source":"JoaquinJCabrera","tweeter_id":"733451022","geo":{"lt":38.87789,"ln":-6.97061,"country":"ES"}},"tweet_id":"382505878433579008"},{"url":"http:\/\/twitter.com\/JoaquinJCabrera\/statuses\/704391730418814978","license":"gnip","citation_ids":[1701501],"posted_on":"2016-02-29T19:44:10+00:00","author":{"id_on_source":"JoaquinJCabrera","tweeter_id":"733451022","geo":{"lt":38.87789,"ln":-6.97061,"country":"ES"}},"tweet_id":"704391730418814978"},{"url":"http:\/\/twitter.com\/AmadeoWals\/status\/382455424185679872","license":"public","citation_ids":[1701501],"posted_on":"2013-09-24T10:44:13+00:00","author":{"name":"Amadeo Wals","url":"https:\/\/es.linkedin.com\/in\/amadeowals","image":"https:\/\/pbs.twimg.com\/profile_images\/845702215457230848\/GqdaaHYu_normal.jpg","description":"Nac\u00ed Especial (Algeciras) y de mayor me hice Especialista (M\u00e9dico).\nSorprenderse, extra\u00f1arse, es comenzar a entender. (cita)","id_on_source":"AmadeoWals","tweeter_id":"500948954","geo":{"lt":37.38241,"ln":-5.97613,"country":"ES"},"followers":623},"tweet_id":"382455424185679872"}]}}